Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 926-949 of 949 matching filings.

Per page
25
Current page
38
DEF 14A File 000-26520

DEF 14A filing

Filing date
11 Jun 2010
Reporting date
16 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-26520

PRE 14A filing

Filing date
28 May 2010
Reporting date
16 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26520

8-K filing

Filing date
27 May 2010
Reporting date
26 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-26520

10-Q filing

Filing date
14 May 2010
Reporting date
31 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 May 2010
Reporting date
10 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 May 2010
Reporting date
04 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 May 2010
Reporting date
03 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26520

8-K filing

Filing date
29 Apr 2010
Reporting date
28 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-156810

424B3 filing

Filing date
01 Apr 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-164058

424B3 filing

Filing date
01 Apr 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-26520

10-K filing

Filing date
31 Mar 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Mar 2010
Reporting date
19 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Mar 2010
Reporting date
16 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26520

8-K filing

Filing date
12 Mar 2010
Reporting date
11 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26520

8-K filing

Filing date
03 Mar 2010
Reporting date
03 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-43603

PLATINUM MONTAUR SC 13GA 12-31-2009

Filing date
26 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26520

8-K filing

Filing date
26 Feb 2010
Reporting date
24 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26520

8-K filing

Filing date
28 Jan 2010
Reporting date
26 Jan 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-164058

424B3 filing

Filing date
28 Jan 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26520

8-K filing

Filing date
20 Jan 2010
Reporting date
20 Jan 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26520

8-K filing

Filing date
11 Jan 2010
Reporting date
11 Jan 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-164058

EFFECT filing

Filing date
07 Jan 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-156810

EFFECT filing

Filing date
07 Jan 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26520

8-K filing

Filing date
06 Jan 2010
Reporting date
01 Jan 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .